Possible Side Effects Mild irritation: Redness, dryness, or itching at the application site may occur in sensitive individuals
Nowak T, Niemiec P, Grczyska-Kosiorz S, Balcerzyk A, Iwanicki T, Krauze J, et al
For more information about the regulatory status of peptides like BPC-157, you can visit the US Anti-Doping Agency's resource on BPC-157, which provides important information for competitive athletes
321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body." FDA's letters to the other manufacturers are similar in their complaints about why their products fall under the agency's regulatory oversight and why the companies are not allowed to market them, despite their oft-cited claims that the products, especially the triple agonists, are for research only